449
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Native and Recombinant Fatty Acid Binding Protein 3 from Fasciola Hepatica as a Potential Antigen

, , &
Pages 60-64 | Published online: 16 Apr 2014
 

ABSTRACT

Lipid-binding proteins are members of widely distributed protein family. They take part in metabolism of different lipophilic ligands and also have a role in physiological activity, metabolism and disposition of essential hydrophobic compounds (fatty acids, phospholipids, eicosanoids, retinoids, etc.) which are important molecules involved in several cellular processes including gene transcription, immune responses etc. Fatty acid binding proteins (FABPs) are mostly cytosolic but several members are excretory-secretory (E-S) proteins. There is a lot of data that helminthic FABPs from E/S products cause antigenic and allergenic reactions.

The aim of the present study is to make a detailed investigation of native and produced recombinant FABP3 as a potential antigen for vaccine creation. The native FABP3 from Fasciola hepatica was purified and recombinant one was expressed in E. coli. Polyclonal antibody was produced against recombinant FABP3 and it was tested on the native one. Obtained results give the opportunity to investigate the effectiveness of the native and recombinant FABP3 as an immunotherapeutic agent and if it could be used for immunoprophilactic.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.